MIBHS

JANUARY 31, 2025

In the age of technology, wearable devices have revolutionized how we approach health and wellness. This blog explores the ways wearable technology can help track heart health, the advantages it offers, and how it contributes to better outcomes for those requiring surgical intervention.

Heart Rhythm 52

Heart Rhythm Technology AFIB Exercise 52

Wellnest

DECEMBER 18, 2023

These groundbreaking developments offer a paradigm shift in the management of resistant hypertension, especially when it is extremely difficult to achieve blood pressure control through conventional means, such as lifestyle modifications and various drug therapies.

Hypertension 52

Hypertension Blood Pressure Ablation Reimbursement 52

Circulation

NOVEMBER 11, 2024

Despite these technological strides, their adoption and sustained use remain limited to health-conscious individuals. The general populace, particularly those indifferent to health management, stands to miss out on the potential benefits of wearable technologies due to a lack of engagement. for 30-second data segments and 80.9%

Hypertension 45

Hypertension Diabetes Blood Pressure Technology 45

Hypertension Journal

JULY 16, 2024

Hypertension, Volume 82, Issue 1 , Page 26-35, January 1, 2025. The 2 critical underlying technologies in AI are used for supervised and unsupervised machine learning. AI can potentially improve hypertension diagnosis and treatment through remote patient monitoring and digital therapeutics.

Hypertension 40

Hypertension Blood Pressure Technology 40

Journal of the American Heart Association

DECEMBER 1, 2023

BackgroundBlood pressure (BP) thresholds for diagnosing and managing hypertension vary for office, home, and ambulatory readings, and between guideline documents. Corresponding BP thresholds for office, home, and ambulatory measurements were determined using Deming regression.

Blood Pressure 40

Blood Pressure Hypertension Document Technology 40

DAIC

MARCH 10, 2025

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) Effect of Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients with Elevated Risk For Major Adverse Cardiovascular Events.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Cardiometabolic Health Congress

NOVEMBER 16, 2023

Recent technological advances, pathophysiology, and pharmacotherapy have contributed to a near-universal recognition of the overlap between ​cardiovascular, ​kidney, and ​metabolic diseases. MIRROR trial supports urate-lowering agent for gout and uncontrolled hypertension.

Kidney Disease 52

Kidney Disease Blood Pressure Diabetes Hospital 52

Circulation

NOVEMBER 11, 2024

Homophobia affects the mental health of the growing San Joaquin Valley (SJV) LGBTQ+ community leading to psychological distress and mental health concerns which can further lead to High Blood Pressure (HBP) and cardiovascular disease (CVD). Each student monitored 2 hypertensive and psychological distressed patients.

Health Disparities 40

Health Disparities Cardiovascular Disease Education Hypertension 40

Vector Remote

APRIL 14, 2023

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.

Pacemaker 52

Pacemaker Technology COVID-19 Arrhythmia 52

Vector Remote

MAY 9, 2023

How to Incorporate Remote Patient Monitoring Into Existing Workflows Remote patient monitoring (RPM) is a service under the telemedicine umbrella that uses specialized technology to track patient health data in real time, integrating care updates into clinic workflows as needed. The benefits of the technology are clear.

Heart Rhythm 52

Heart Rhythm Technology Blood Pressure Defibrillator 52

DAIC

JANUARY 19, 2024

milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. Orchestra BioMed and Medtronic, Inc. Kowal, M.D.,

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105

Hypertension Journal

APRIL 15, 2025

Hypertension, Ahead of Print. Cuffless blood pressure (BP) measurement offers considerable potential for clinical practice but is a challenging technological field. Yet, publications and regulatory-cleared devices continue to rise, seemingly implying technological advancements.

Blood Pressure 66

Blood Pressure Technology Hypertension Research 66

MIBHS

FEBRUARY 28, 2025

Genes influence various biological processes, including cholesterol metabolism, blood pressure regulation, and the strength and structure of your heart and blood vessels. Common Heart Diseases with Genetic Links Coronary Artery Disease (CAD): CAD occurs when the arteries supplying blood to the heart become narrowed or blocked.

Genetic predisposition 52

Genetic predisposition Heart Disease Cholesterol Blood Pressure 52

DAIC

APRIL 1, 2024

Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We What is Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

DAIC

FEBRUARY 27, 2024

milla1cf Tue, 02/27/2024 - 17:29 February 27, 2024 — Aria CV, Inc , a developer of medical devices treating pulmonary hypertension, today announced the first patient was implanted with the Gen 2 Aria CV Pulmonary Hypertension System as part of the ASPIRE PH clinical trial at Ascension St. Ashwin Ravichandran and Scott Hittinger.

Pulmonary 110

Pulmonary Hypertension Heart Failure Blood Pressure 110

DAIC

MAY 21, 2024

A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight. of their body weight.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

Hypertension Journal

MARCH 1, 2024

Hypertension, Ahead of Print. and angiotensin II type-1 receptor, SMC-MR contributes to myogenic tone and vasoconstriction, thereby contributing to systemic blood pressure. By regulating expression of the L-type calcium channel subunit Cav1.2

Blood Pressure 40

Blood Pressure Aortic valve Heart Failure Hypertension 40

Stroke Journal

JANUARY 30, 2025

Effective blood pressure (BP) management is crucial for reducing stroke and CVD risk, yet controlled hypertension remains suboptimal especially among minority populations. Risk factors included history of hypertension (37.1%), heart disease (5.6%), stroke (2.1%), and diabetes (29.1%). SD=15.8); 63.8% were female, 76.2%

Blood Pressure 40

Blood Pressure Education Hypertension Strokes 40

Cardiometabolic Health Congress

JULY 17, 2024

Aprocitentan (Tryvio) Approved: March 20, 2024 Indication: Hypertension in adults Administration: Oral Mechanism: Endothelin A and B receptor antagonist Developer: Idorsia Pharmaceuticals Significance: First and only FDA-approved endothelin receptor antagonist for high blood pressure that remains uncontrolled with existing treatments.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

Circulation

FEBRUARY 25, 2024

This is most evident in hypertension where several small interfering RNA–based drugs have proven to be effective in managing high blood pressure in several clinical trials. mRNA technology may provide the platform for the expression of paracrine factors for myocardial protection and regeneration.

COVID-19 102

COVID-19 Cardiovascular Disease Blood Pressure Technology 102

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Cardiometabolic Health Congress

NOVEMBER 22, 2024

From breakthrough medications to innovative technologies, there is a lot for cardiometabolic clinicians professionals to celebrate. The study found reductions in the apnea-hypopnea index (AHI), inflammation markers, and systolic blood pressure, making it a promising dual-purpose medication for managing obesity-related complications.

Blood Pressure 59

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease 59

DAIC

JANUARY 14, 2025

13, 2025 Medtronic plc recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension.

CMS 52

CMS Medicare Blood Pressure Medicaid 52

Dr. S. Venkatesan MD

APRIL 3, 2025

Hemodynanmic of normal delivery Natural delivery involves the physiological stress of labor, which includes increased cardiac output, blood pressure fluctuations, and oxygen demand, peaking at 50-80% above baseline during contractions and pushing. For women with significant heart disease (e.g.,

Heart Disease 45

Heart Disease Blood Pressure Heart Failure Aortic 45

DAIC

JANUARY 27, 2025

13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension. 11, 2025.

CMS 52

CMS Blood Pressure Medicare Hypertension 52